Stripping away M&A and financial things like indebtedness, all for-profit healthcare businesses will succeed or fail based on these three parameters. And all can be measured along them, too.
Dentists in the UK are facing tough times – including the largest provider of NHS dentistry in the country, Mydentist. But as revenue falls and it begins to shed practices, has it bitten off more than it can chew? Healthcare Europa looks at its recent results, asks where things have gone wrong – and speaks to the company to ask what is being done to put things back on track.
Pan- European and Indian healthcare and diagnostics provider Medicover is entering the wellness market, in a move that could provide interesting synergies with its corporate healthcare offering, mainly in Poland and Romania. The company's H1 and second quarter financials show losses in the Indian and UK fertility markets, but strong growth in Eastern Europe. We […]
After Malaysian healthcare giant IHH's $1.3bn buy-out of controversy-riddled Fortis Healthcare, the Indian hospital group's diagnostic lab SRL has launched a major push to improve its dwindling sales. Is it worth trying to impress incoming management, or will Fortis drop the business? We speak to an analyst to find out more.
Brazilian dental plan specialist Odontoprev saw its share drop 7% on H1 results, yet it still paid out in dental services just 45.5% of its second quarter revenue!
Before British primary care digital health player Babylon came along, the Rwandan government had never signed a contract with a private healthcare provider. A universal healthcare coverage scheme called Mutuelles de Santé had been operating in the country since 1999, but ten years later was spending 9.7% of GDP on health. The government and its citizens needed a means to make healthcare more accessible and affordable: so in 2016 it invited a private digital health platform to help connect patients to doctors.
Australian private hospital and pathology services provider Healthscope has divested its pathology operations in Singapore, Malaysia and Vietnam to private equity firm TPG Capital Asia.
Private hospitals in the UK are seeing NHS revenues drop after the public health services provider relaxed its rules governing fines for waiting times for treatment.
Eastern European hospital group Penta Hospitals' enterprising CEO Attila Vegh was the surprising choice to replace the soon-to-be-departing CEO of pan-European hospital group Capio, Thomas Beglund. But with Vegh's fingerprints all over Penta's plans for expansion - and his face still all over its website - where does the Czechia-based group go from here. Healthcare Europa speaks to a lawyer whose firm has advised the group in the past to find out more.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
